Introduction
A sex-related dimorphism in immune capabilities is thought to be related to the physiological effects of sex hormones on the immune system. [1] [2] [3] [4] [5] Generally, at least at physiological concentrations, oestrogens exert immunostimulatory effects, whereas androgens are immunosuppressive and a preponderance of autoimmune diseases in females compared with males is well recognized. In rheumatoid arthritis (RA), the synovial tissue is widely infiltrated by mononuclear cells and is considered the target tissue for a 'sexual dimorphism' in the immune response. [2] [3] [4] [5] [6] [7] Sex hormones seem to play a role in immunomodulation via receptor-mediated mechanisms.
High affinity androgen receptors (AR) have already been detected in human maturing thymocytes. -11 However, it is only recently that androgen and oestrogen receptors have been detected in synovial macrophages (mCs) of normal and rheumatoid synovial tissues, by immunostaining of cryosections and by biochemical characterization in homogenized tissues. 12, 13 The presence of androgen receptors on mCs induced us to analyse the metabolic pathway for androgens.
MCs were found to be capable of effectively metabolizing testosterone (Tes) to the bioactive dihydrotestosterone (DHT (Fig. I(B) All these observations may represent the basis for the effectiveness of androgen replacement therapy in RA as well as in Klinefelter's patients. 29, 32 Recently the administration of dehydroepiandrosterone (DHEA), an adrenal hormone with mild intrinsic androgenic activity, has been reported to improve the disease activity in SLE patients. 3 In conclusion, androgens may at least partially exert their immunosuppressive activity by acting on human activated ms through respective receptormediated mechanisms. 4 These findings underscore the importance of sex hormones in immune system regulation and consequently confirm that both androgen and oestrogen imbalance may have significant implications in autoimmunity. 
